ATE538135T1 - Verbindungen auf peptidbasis - Google Patents
Verbindungen auf peptidbasisInfo
- Publication number
- ATE538135T1 ATE538135T1 AT05752383T AT05752383T ATE538135T1 AT E538135 T1 ATE538135 T1 AT E538135T1 AT 05752383 T AT05752383 T AT 05752383T AT 05752383 T AT05752383 T AT 05752383T AT E538135 T1 ATE538135 T1 AT E538135T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- based compounds
- angiogenesis
- optical imaging
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 238000012634 optical imaging Methods 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20042523 | 2004-06-16 | ||
| PCT/NO2005/000210 WO2005123768A1 (en) | 2004-06-16 | 2005-06-15 | Peptide-based compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE538135T1 true ATE538135T1 (de) | 2012-01-15 |
Family
ID=34979156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05752383T ATE538135T1 (de) | 2004-06-16 | 2005-06-15 | Verbindungen auf peptidbasis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7897142B2 (enExample) |
| EP (1) | EP1765863B1 (enExample) |
| JP (1) | JP5280683B2 (enExample) |
| CN (2) | CN1968963A (enExample) |
| AT (1) | ATE538135T1 (enExample) |
| BR (1) | BRPI0512209A (enExample) |
| ES (1) | ES2376557T3 (enExample) |
| PL (1) | PL1765863T3 (enExample) |
| RU (1) | RU2393167C2 (enExample) |
| WO (1) | WO2005123768A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2719088T3 (es) * | 2001-07-10 | 2019-07-08 | Ge Healthcare Ltd | Compuestos con base peptídica para localizar receptores de integrina |
| BRPI0518328A2 (pt) * | 2004-11-22 | 2008-11-11 | Ge Healthcare As | agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica |
| ITMI20050328A1 (it) | 2005-03-03 | 2006-09-04 | Univ Degli Studi Milano | Composti peptidomimetrici e preparazione di derivati biologicamente attivi |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| EP3673922A1 (en) | 2008-03-14 | 2020-07-01 | VisEn Medical, Inc. | Integrin targeting agents and methods of using same |
| US20100291706A1 (en) * | 2009-05-15 | 2010-11-18 | Millipore Corporation | Dye conjugates and methods of use |
| EP2314597B1 (en) * | 2009-10-21 | 2012-11-28 | Cyanagen Srl | Kit and method for the labelling of biomolecules |
| CN103052690A (zh) | 2010-06-29 | 2013-04-17 | 通用电气医疗集团股份有限公司 | 染料组合物和染料合成 |
| GB201010878D0 (en) | 2010-06-29 | 2010-08-11 | Ge Healthcare As | Dye compositiion and dye syntheses |
| US9592307B2 (en) | 2012-07-20 | 2017-03-14 | Canon Kabushiki Kaisha | Compound and photoacoustic imaging contrast medium containing the compound |
| WO2014055253A1 (en) * | 2012-10-04 | 2014-04-10 | The General Hospital Corporation | Methods of synthesizing and using peg-like fluorochromes |
| WO2015059368A1 (fr) * | 2013-09-02 | 2015-04-30 | L'oreal | Procede de coloration des fibres keratiniques a partir de colorants cationiques styryles disulfures, et composition comprenant lesdits colorants |
| CN107022350A (zh) * | 2017-04-20 | 2017-08-08 | 深圳大学 | 一种荧光造影材料及其制备方法与应用 |
| CN107739528A (zh) * | 2017-09-30 | 2018-02-27 | 武汉工程大学 | 一种五肽改性菁染料化合物及其制备方法和应用 |
| IL287989B2 (en) | 2019-05-13 | 2025-07-01 | Bracco Imaging Spa | Modified cyanine dyes and their conjugates |
| EP4137502A4 (en) * | 2020-03-30 | 2024-02-28 | Ichimaru Pharcos Co., Ltd. | Vipr2 antagonist peptide |
| EP4267971A4 (en) | 2021-04-07 | 2024-08-07 | Becton, Dickinson and Company | Water-soluble fluorescent polymeric dyes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4445065A1 (de) * | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
| DE19917713A1 (de) * | 1999-04-09 | 2000-10-19 | Diagnostikforschung Inst | Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik |
| ATE298763T1 (de) * | 2000-04-12 | 2005-07-15 | Amersham Health As | Integrinbindende peptidderivate |
| ES2719088T3 (es) * | 2001-07-10 | 2019-07-08 | Ge Healthcare Ltd | Compuestos con base peptídica para localizar receptores de integrina |
| NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
-
2005
- 2005-06-15 WO PCT/NO2005/000210 patent/WO2005123768A1/en not_active Ceased
- 2005-06-15 EP EP05752383A patent/EP1765863B1/en not_active Expired - Lifetime
- 2005-06-15 AT AT05752383T patent/ATE538135T1/de active
- 2005-06-15 JP JP2007516412A patent/JP5280683B2/ja not_active Expired - Fee Related
- 2005-06-15 CN CNA2005800198740A patent/CN1968963A/zh active Pending
- 2005-06-15 PL PL05752383T patent/PL1765863T3/pl unknown
- 2005-06-15 CN CNA2005800273703A patent/CN101001870A/zh active Pending
- 2005-06-15 RU RU2006144279/04A patent/RU2393167C2/ru not_active IP Right Cessation
- 2005-06-15 BR BRPI0512209-0A patent/BRPI0512209A/pt not_active IP Right Cessation
- 2005-06-15 ES ES05752383T patent/ES2376557T3/es not_active Expired - Lifetime
- 2005-06-15 US US11/570,156 patent/US7897142B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5280683B2 (ja) | 2013-09-04 |
| EP1765863A1 (en) | 2007-03-28 |
| CN1968963A (zh) | 2007-05-23 |
| BRPI0512209A (pt) | 2008-02-19 |
| US7897142B2 (en) | 2011-03-01 |
| EP1765863B1 (en) | 2011-12-21 |
| RU2006144279A (ru) | 2008-07-27 |
| WO2005123768A1 (en) | 2005-12-29 |
| ES2376557T3 (es) | 2012-03-14 |
| JP2008504237A (ja) | 2008-02-14 |
| RU2393167C2 (ru) | 2010-06-27 |
| CN101001870A (zh) | 2007-07-18 |
| PL1765863T3 (pl) | 2012-05-31 |
| US20080095715A1 (en) | 2008-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE538135T1 (de) | Verbindungen auf peptidbasis | |
| Wang et al. | A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain | |
| NO20074036L (no) | Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer | |
| EP3408349A4 (en) | CHEMILUMINESCENT PROBES FOR DIAGNOSIS AND IN VIVO | |
| UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
| EA201100231A1 (ru) | Диагностический анализ на основе антител | |
| CY1115906T1 (el) | Ανθρωποποιημενα αντισωματα κατα του βητα αμυλοειδους | |
| SV2008002511A (es) | Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos | |
| NO20024932D0 (no) | Kontrastmiddel | |
| ECSP088508A (es) | Antagonistas de neuropilina | |
| EP1732602A4 (en) | CYTOTOXICITY TRANSFER OF CELLS WITH NOTES ON SURFACE EXPRESSION OF MCSP | |
| MX2015013219A (es) | Imagenologia por fluorescencia de enfermedades inflamatorias. | |
| ATE551073T1 (de) | Markierte hgf-bindende peptide für bildgebung | |
| NO20033115D0 (no) | Peptid-baserte forbindelser | |
| EA200870502A1 (ru) | Белки слияния на основе rage, их композиции и способы их применения | |
| CR10654A (es) | Agentes que comprenden compuestos marcados con 18f y metodos relacionados | |
| CR8230A (es) | Sondas para enfermedades en las cuales se acumula amiloide, agentes para tincion del amiloide, farmacos para tratamiento y profilaxis de enfermedades con amiloide acumulado y sondas para diagnostico de ovillos neuro fibrilares yagentes... | |
| CO2018000414A2 (es) | Inmunoconjugados de il22 | |
| EP2385114A4 (en) | CANCER TREATMENT DIAGNOSIS WITH ANTI-TM4SF20 ANTIBODY | |
| MX2021013251A (es) | Tintes de cianina modificados y conjugados de los mismos. | |
| EP1907018A4 (en) | DIAGNOSIS AND FORECASTING DIABETES | |
| WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
| MX386900B (es) | Compuestos para formacion de imagenes de agregados de proteinas tau. | |
| MA34291B1 (fr) | Compositions et méthodes de diagnostic et de traitement d'une tumeur | |
| CY1114604T1 (el) | Ανθρωποποιημενο αντισωμα εναντιον αμυλοειδους βητα |